Has Venoarterial ECMO Been Underutilized in COVID-19 Patients? (original) (raw)
2020, Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
AI-generated Abstract
This study investigates the utilization of venoarterial (V-A) extracorporeal membrane oxygenation (ECMO) in COVID-19 patients, highlighting its underutilization despite increasing severity in respiratory and cardiovascular compromise related to the virus. The authors argue that V-A ECMO represents a marginal proportion of ECMO support provided, suggesting potential gaps in the treatment of patients with severe COVID-19 complications. The paper calls for improved organization and resource allocation in ECMO centers to optimize patient outcomes and emphasizes the necessity of tailored treatment approaches.
Sign up for access to the world's latest research.
checkGet notified about relevant papers
checkSave papers to use in your research
checkJoin the discussion with peers
checkTrack your impact
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.